Vir Biotechnology VIR
NASDAQ VIR
$13.15 -0.50 (-3.63%)
At close: Nov 10, 2026 · 4:00 PM EST

Vir Biotechnology (VIR) Net Margin (2018 - 2026)

Updated

Vir Biotechnology (VIR) reported Net Margin of -51197.87% for Q3 2026, up 16777.54 percentage points from -67975.42% a year earlier but down 51231.39 percentage points from the prior quarter.

Analysis

Vir Biotechnology (VIR) Net Margin (2018 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Vir Biotechnology's Net Margin came in at -60.94%, up 2902.60 percentage points year-over-year; for FY2025, it came in at -638.87%, up 64.53 percentage points from FY2024.

  • Net Margin has a five-year change of -247.79 percentage points (FY2020 to FY2025).
  • By year, Net Margin came in at -703.40% in FY2024 (+10.29 pp), -713.69% in FY2023 (-745.62 pp), 31.92% in FY2022 (-16.33 pp) and 48.25% in FY2021 (+439.34 pp).
  • Five-year quarterly Net Margin spans a low of -433431.03% in Q1 2026 and a high of 64.63% in Q4 2021.
  • Year over year, Net Margin gained in three of the last eight quarters, with an average year-over-year change of -58796.99 percentage points.
  • The high point for year-over-year Net Margin in five years was Q3 2026 (a gain of 16777.54 percentage points); the low point was Q1 2026 (a drop of 429441.42 percentage points).
  • Per Business Quant data, the three quarters before Q3 2026 came in at 33.51% (Q2 2026), -433431.03% (Q1 2026) and -66.99% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 26.44%
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 0.83%
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 24.24%
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 28.01%
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 22.65%
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 16.30%
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 37.28%
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 29.27%
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 19.55%
10 Vir Biotechnology 2.28 Bn 363.84 Mn 188,000.00 -51,197.87%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -51,197.87%
Jun 30, 2026 33.51%
Mar 31, 2026 -433,431.03%
Dec 31, 2025 -66.99%
Sep 30, 2025 -67,975.42%
Jun 30, 2025 -9,139.87%
Mar 31, 2025 -3,989.61%
Dec 31, 2024 -845.23%
Sep 30, 2024 -8,979.71%
Jun 30, 2024 -4,500.10%
Mar 31, 2024 -115.79%
Dec 31, 2023 -690.85%
Sep 30, 2023 -6,192.23%
Jun 30, 2023 -5,129.71%
Mar 31, 2023 -223.80%
Dec 31, 2022 -205.63%
Sep 30, 2022 46.81%
Jun 30, 2022 -188.27%
Mar 31, 2022 42.08%
Dec 31, 2021 64.63%
API Access

Vir Biotechnology Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=VIR&period=max&api_key=YOUR_API_KEY